| Caffeine and risk of Parkinson's disease in a large cohort of men and women N Palacios, X Gao, ML McCullough, MA Schwarzschild, R Shah, ... Movement Disorders 27 (10), 1276-1282, 2012 | 259 | 2012 |
| Obesity, diabetes, and risk of Parkinson's disease N Palacios, X Gao, ML McCullough, EJ Jacobs, AV Patel, T Mayo, ... Movement Disorders 26 (12), 2253-2259, 2011 | 189 | 2011 |
| Prospective study of chemical exposures and amyotrophic lateral sclerosis MG Weisskopf, N Morozova, EJ O’Reilly, ML McCullough, EE Calle, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (5), 558-561, 2009 | 176 | 2009 |
| Protein–RNA interactions: exploring binding patterns with a three-dimensional superposition analysis of high resolution structures N Morozova, J Allers, J Myers, Y Shamoo Bioinformatics 22 (22), 2746-2752, 2006 | 173 | 2006 |
| Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence N Palacios, A Alonso, H BrØnnum-Hansen, A Ascherio Annals of epidemiology 21 (7), 536-542, 2011 | 136 | 2011 |
| Particulate matter and risk of Parkinson disease in a large prospective study of women N Palacios, KC Fitzgerald, JE Hart, MG Weisskopf, MA Schwarzschild, ... Environmental Health 13, 1-9, 2014 | 95 | 2014 |
| Diet and amyotrophic lateral sclerosis N Morozova, MG Weisskopf, ML McCullough, KL Munger, EE Calle, ... Epidemiology 19 (2), 324-337, 2008 | 94 | 2008 |
| Prospective study of occupation and amyotrophic lateral sclerosis mortality MG Weisskopf, ML McCullough, N Morozova, EE Calle, MJ Thun, ... American journal of epidemiology 162 (12), 1146-1152, 2005 | 85 | 2005 |
| Air pollution and Parkinson’s disease–evidence and future directions N Palacios Reviews on Environmental Health 32 (4), 303-313, 2017 | 75 | 2017 |
| A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses’ health study cohort N Palacios, K Fitzgerald, AL Roberts, JE Hart, MG Weisskopf, ... Environmental health perspectives 122 (9), 933-938, 2014 | 75 | 2014 |
| Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women N Palacios, X Gao, E O'Reilly, M Schwarzschild, ML McCullough, T Mayo, ... Movement Disorders 27 (8), 980-987, 2012 | 74 | 2012 |
| Air pollution and risk of Parkinson’s disease in a large prospective study of men N Palacios, KC Fitzgerald, JE Hart, M Weisskopf, MA Schwarzschild, ... Environmental health perspectives 125 (8), 087011, 2017 | 73 | 2017 |
| Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses N Palacios, KL Munger, KC Fitzgerald, JE Hart, T Chitnis, A Ascherio, ... Environment international 109, 64-72, 2017 | 60 | 2017 |
| Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women N Palacios, M Weisskopf, K Simon, X Gao, M Schwarzschild, A Ascherio Parkinsonism & related disorders 16 (6), 370-375, 2010 | 58 | 2010 |
| Variations in gender ratios support the connection between smoking and Parkinson's disease N Morozova, EJ O'Reilly, A Ascherio Movement disorders: official journal of the Movement Disorder Society 23 (10 …, 2008 | 53 | 2008 |
| Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women N Palacios, KC Hughes, E Cereda, MA Schwarzschild, A Ascherio Movement Disorders 33 (9), 1492-1496, 2018 | 39 | 2018 |
| RLS in middle aged women and attention deficit/hyperactivity disorder in their offspring X Gao, K Lyall, N Palacios, AS Walters, A Ascherio Sleep medicine 12 (1), 89-91, 2011 | 28 | 2011 |
| Applications of metabolomics in the study and management of preeclampsia: a review of the literature RS Kelly, RT Giorgio, BL Chawes, NI Palacios, KJ Gray, H Mirzakhani, ... Metabolomics 13, 1-20, 2017 | 27 | 2017 |
| Metagenomics of the gut microbiome in Parkinson's disease: prodromal changes N Palacios, J Wilkinson, K Bjornevik, MA Schwarzschild, L McIver, ... Annals of neurology 94 (3), 486-501, 2023 | 26 | 2023 |
| The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension M Li, Y Wang, N Ndiwane, MB Orner, N Palacios, B Mittler, D Berlowitz, ... PLoS One 16 (3), e0248652, 2021 | 24 | 2021 |
